Best Researcher Award
Bilal Ahmad
University of Johannesburg, South Africa
Bilal Ahmad is a researcher and academic affiliated with the University of Johannesburg, South Africa, whose scholarly work focuses on machine learning applications, computational drug discovery, and artificial intelligence-driven biomedical analysis. His research contributions primarily explore drug–target interaction prediction, explainable artificial intelligence, and computational methodologies for healthcare innovation.[1] Ahmad has contributed to interdisciplinary research integrating machine learning, bioinformatics, and cheminformatics in the context of pharmaceutical sciences and Alzheimer’s disease research.[2]
He has served in academic teaching and research capacities in South Africa and Pakistan while pursuing doctoral research in Electrical and Electronic Engineering Science at the University of Johannesburg.[3] His publication record includes work in computational biotechnology and artificial intelligence applications for biomedical sciences.[4]
Abstract
This article presents an academic overview of Bilal Ahmad and his research profile within the field of machine learning applications and computational drug discovery. His work emphasizes artificial intelligence methodologies for biomedical data analysis, predictive modeling, and drug–target interaction analysis. The profile summarizes his educational background, research activities, scientific contributions, publication record, and academic suitability for recognition under the International Research Data Analysis Excellence & Awards program.[1][4]
Keywords
Artificial Intelligence, Machine Learning, Computational Drug Discovery, Drug–Target Interaction, Explainable AI, Bioinformatics, Alzheimer’s Disease Research, Biomedical Data Analysis, Deep Learning, Computational Biotechnology.
Introduction
The growing integration of artificial intelligence and computational modeling in healthcare and pharmaceutical sciences has created new opportunities for biomedical innovation. Researchers working at the intersection of machine learning and drug discovery contribute toward accelerating therapeutic identification, optimizing predictive analysis, and enhancing biological data interpretation.[5]
Bilal Ahmad has contributed to this interdisciplinary field through research centered on drug–target interaction prediction, ensemble learning, explainable artificial intelligence, and computational methodologies applicable to Alzheimer’s disease drug discovery.[2] His academic trajectory reflects engagement with applied machine learning, computational biology, and scientific data analysis in higher education and research environments.[3]
Research Profile
Bilal Ahmad is currently affiliated with the Department of Electrical and Electronic Engineering Science at the University of Johannesburg, where he serves as a lecturer and doctoral researcher.[1] His doctoral research investigates advanced artificial intelligence and machine learning methodologies for drug discovery applications, particularly in relation to neurodegenerative diseases.[2]
His educational background includes a Master of Computer Science degree from COMSATS University Islamabad and a Bachelor of Computer Science degree from the University of Malakand.[1] He has also participated in international mobility research initiatives through collaborative academic activities with the University of Pisa in Italy.[3]
The research profile of Ahmad demonstrates specialization in deep learning, explainable AI, molecular descriptor analysis, QSAR modeling, and bioactivity data curation. His technical expertise includes scientific computing frameworks such as TensorFlow, PyTorch, Scikit-learn, and cheminformatics platforms including RDKit and DeepChem.[2]
Research Contributions
Ahmad’s research contributions are primarily associated with computational strategies for drug–target interaction prediction and machine learning-based biomedical analytics. His scholarly activities emphasize the development of predictive frameworks capable of assisting therapeutic discovery processes through data-driven methodologies.[4]
His research work includes investigations into ensemble learning systems, graph-based prediction methods, explainable artificial intelligence techniques, and ligand-based computational frameworks designed for Alzheimer’s disease-related therapeutic research. These studies contribute toward improving interpretability and predictive performance in machine learning models used within pharmaceutical research environments.[5]
In addition to research publications, Ahmad has participated in academic teaching, tutoring, and conference coordination activities. His teaching experience includes machine learning, signal processing, operating systems, artificial intelligence, and advanced database systems.[3]
Publications
The publication record of Bilal Ahmad includes peer-reviewed and submitted research contributions focusing on machine learning methodologies and computational biotechnology.[4]
- Ahmad, B., Ouahada, K., & Hamam, H. (2026). Machine learning for drug-target interaction prediction: A comprehensive review of models, challenges, and computational strategies. Computational and Structural Biotechnology Journal.[4]
- Jabeen, F., Gul, F., Shah, S., Ahmed, B., & Jabeen, S. (2022). Exploration of epidemic outbreaks using machine and deep learning techniques. International Conference on Cyber Security, Cybercrimes, and Smart Emerging Technologies, Riyadh, Saudi Arabia.
- Submitted manuscripts include research on graph-based drug–target interaction prediction, explainable artificial intelligence for cholinesterase inhibitor prediction, and deep learning frameworks for Alzheimer’s disease drug discovery.
Research Impact
According to available Scopus metrics, Bilal Ahmad has an indexed author profile associated with research outputs in machine learning and computational biotechnology. The profile records citations associated with published scholarly work and reflects emerging academic engagement in artificial intelligence-based biomedical applications.
The interdisciplinary nature of his work contributes to ongoing developments in healthcare informatics, computational biology, and intelligent therapeutic discovery systems. His research direction aligns with current scientific efforts to apply explainable and interpretable artificial intelligence methods to biomedical and pharmaceutical challenges.[5]
Award Suitability
Bilal Ahmad’s research profile demonstrates alignment with the objectives of the International Research Data Analysis Excellence & Awards program through his work in machine learning applications, biomedical data interpretation, and computational drug discovery. His academic activities combine research, teaching, and interdisciplinary collaboration within emerging areas of artificial intelligence and healthcare analytics.[3]
The integration of explainable artificial intelligence, graph-based methodologies, and predictive drug discovery systems within his research portfolio reflects contemporary scientific priorities associated with intelligent healthcare technologies and computational pharmaceutical sciences.
Conclusion
Bilal Ahmad represents an emerging academic researcher working in the field of artificial intelligence-driven computational drug discovery and machine learning applications. His research activities, educational background, and interdisciplinary focus contribute toward ongoing developments in biomedical informatics and predictive healthcare technologies.[1][4]
The combination of academic teaching experience, technical expertise, and research-oriented contributions supports his recognition within scholarly platforms dedicated to data analysis, innovation, and scientific excellence.
External Links
References
- Ahmad, B. (2026). Advanced AI and ML Techniques for Drug Discovery. Doctoral research project, University of Johannesburg.
https://orcid.org/0009-0008-5254-8779
- Ahmad, B., Ouahada, K., & Hamam, H. (2026). Machine learning for drug-target interaction prediction: A comprehensive review of models, challenges, and computational strategies. Computational and Structural Biotechnology Journal.
https://doi.org/10.1016/j.csbj.2025.12.033
- Jabeen, F., Gul, F., Shah, S., Ahmed, B., & Jabeen, S. (2022). Exploration of epidemic outbreaks using machine and deep learning techniques. International Conference on Cyber Security, Cybercrimes, and Smart Emerging Technologies.
https://doi.org/10.1007/978-3-031-21101-0_23
- Elsevier. (n.d.). Scopus author details: Bilal Ahmad, Author ID 60333188500. Scopus.
https://www.scopus.com/authid/detail.uri?authorId=60333188500
- International Research Data Analysis Excellence & Awards. (2026). Award nomination and research excellence recognition framework.
https://researchdataanalysis.com/